Depomed, Argos Therapeutics, Microbot Medical Stocks Moving Today

Healthcare stocks Depomed, Argos Therapeutics, and Microbot Medical are making huge moves on the charts today

Feb 22, 2017 at 11:43 AM
facebook X logo linkedin

Stocks are fighting to hold onto gains this morning. Among specific equities in focus are healthcare stocks Depomed Inc (NASDAQ:DEPO), Argos Therapeutics Inc (NASDAQ:ARGS), and Microbot Medical Inc (NASDAQ:MBOT). Here's a quick look at what's moving shares of DEPO, ARGS, and MBOT.

Depomed Rallies After Strong Results

Though the stock has pared some of its earlier gains, DEPO was last seen 6.9% higher at $16.86, after the company's fourth-quarter earnings report impressed the Street. However, Morgan Stanley still reduced its price target to $19 from $20. Depomed Inc is no stranger to skepticism, with over one-quarter of its float controlled by short sellers, which equates to more than two weeks' worth of buying power, at average daily volumes. Looking back, these bears have a case, as DEPO had been trending lower since peaking near $27 in late September. 

Argos Paces Worst Stocks on Nasdaq

ARGS is selling off after the company revealed an independent committee suggested it should discontinue its study of a renal cancer treatment. The shares were last seen 67% lower at $1.45, earning a spot on the short-sale restricted (SSR) list, and earlier touching a record low of $1.25. In fact, the equity is the worst percentage decliner on the Nasdaq. Many traders were gearing up for an Argos Therapeutics Inc sell-off, too. Specifically, short interest on the shares is now at an all-time high, after a 10.3% jump in the last reporting period. 

Microbot Medical Explodes On Patent News

MBOT received a significant technology patent allowance, covering a device meant to prevent shunt stenosis. Now, the shares have soared 90% to $9.71 -- the best Nasdaq stock today. Even so, it's been a tough year for shareholders, as the stock's 12-month high stands at $48.60, touched last February. These heavy losses have attracted short sellers, with short interest on Microbot Medical Inc surging 30.7% in the last reporting period. At their typical trading volume, it would take over a week to cover the shorted MBOT shares.

Get a jump-start on the day's stock market news with Schaeffer's free Opening View newsletter.

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI